Ausdal Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Sell |
770
-10
| -1% | -$4.45K | 0.02% | 517 |
|
|
2025
Q1 | $378K | Buy |
780
+23
| +3% | +$11.2K | 0.03% | 447 |
|
|
2024
Q4 | $305K | Buy |
757
+43
| +6% | +$17.3K | 0.03% | 445 |
|
|
2024
Q3 | $332K | Buy |
714
+30
| +4% | +$14K | 0.03% | 388 |
|
|
2024
Q2 | $321K | Buy |
684
+97
| +17% | +$45.5K | 0.03% | 369 |
|
|
2024
Q1 | $245K | Buy |
587
+94
| +19% | +$39.3K | 0.03% | 406 |
|
|
2023
Q4 | $201K | Buy |
+493
| New | +$201K | 0.02% | 425 |
|
|
2022
Q1 | – | Sell |
-14,981
| Closed | -$3.29M | – | 523 |
|
|
2021
Q4 | $3.29M | Buy |
+14,981
| New | +$3.29M | 0.44% | 60 |
|
|
2016
Q1 | – | Sell |
-31
| Closed | -$4K | – | 1007 |
|
|
2015
Q4 | $4K | Buy |
+31
| New | +$4K | ﹤0.01% | 1133 |
|